20468 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN
#602Solubility of therapeutic agents
#603Methods, agents and compositions for treatment of inflammatory conditions
#604ESTRUS SYNCHRONIZATION PREPARATIONS AND EFFECTIVE CIDR-LESS PROTOCOLS
#605Treatment of prostate carcinoma
#606Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
#607Method of treating organophosphate intoxication by administration of neurosteroids
#608Uses of hypoxia-inducible factor inhibitors
#609NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#610Compositions and methods for maintaining cognitive function
#611Implants for localized drug delivery and methods of use thereof
#612COMPOSITIONS FOR NAIL AND SKIN TREATMENT
#613COMPOSITIONS AND KITS FOR COMPOUNDING PHARMACEUTICALS
#614OTIC FORMULATIONS FOR THE TREATMENT OF CERUMINOSIS
#615Vaginal inserted estradiol pharmaceutical compositions and methods
#616Method for treatment of primary hormone resistant endometrial and breast cancers
#617Method of treating cancer using selective estrogen receptor modulators
#618GEL COMPOSITIONS FOR TRANSDERMAL DELIVERY TO MAXIMIZE DRUG CONCENTRATIONS IN THE STRATUM CORNEUM AND SERUM AND METHODS OF USE THEREOF
#619USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE
#620Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
#621Methods for treating insulin resistance and for sensitizing patients to GLP1 agonist therapy
#622Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
#623Use of semi-fluorinated alkanes in transdermal therapeutic systems
#624METHODS FOR ASSESSING VAGINAL ATROPHY
#625Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer
#626Anti-scalping pharmaceutical packaging film
#627General anesthetics that are not neurotoxic
#628Ship inhibition to induce activation of natural killer cells
#629TARGETED POLYMERIC NANO-COMPLEXES AS DRUG DELIVERY SYSTEM
#630Targeted therapeutics
#631PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#632NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING
#633Chemical induction of lactation in prepubescent non-human mammals
#634SPATIOTEMPORALLY MULTICONTROLLABLE INTELIGENT DRUG-ELUTING STENT
#635TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY
#636Non-reducing end unsaturated mannuronic acid oligosaccharides and compositions containing same as active ingredient
#637Targeted therapeutics
#638Methods of adminstering elagolix
#639MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#640Estrogen combination for treatment of multiple sclerosis
#641Neuro-protective agents and uses thereof
#642Biomarkers for painful intervertebral discs and methods of use thereof
#643COMPOSITION FOR THE PREVENTION AND THERAPY OF TUMOR DISEASES
#6447-dehydrocholesterol derivatives and methods using same
#645FULVESTRANT COMPOSITIONS
#646Combination therapy for skin disorders
#647Pharmaceutical compositions comprising silica microspheres
#648TRANSDERMAL DRUG DELIVERY SYSTEMS FOR LEVONORGESTREL AND ETHINYL ESTRADIOL
#649Breast Cancer Biomarker
#650Process for purification and isolation of estrogens
#651TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER
#652Vaginal composition and use thereof
#653METHODS OF TREATMENT WITH TASELISIB
#654ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
#655Pharmaceutical compositions containing testosterone and an aromatase inhibitor
#656Hormone delivery system and method
#657Methods and compositions for the treatment of cancer
#658COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
#659Controlled release fatty acid compositions for use in body reconstruction and body-shaping
#660Method of treating cancer using selective estrogen receptor modulators
#661Nested particles and the use thereof for coordinated delvery of active agents
#662Orally disintegrating solid dosage unit containing an estetrol component
#663Use of heptyl glucoside as skin penetration enhancer in transdermal pharmaceutical compositions
#664Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
#665Libido-enhancing therapeutic and use
#666Topical Pharmaceutical Cosmetic and Disinfectant Compositions Comprising Phosphatidylcholine
#667Methods for Inhibiting the Development of Huntington's Disease
#668ENHANCED TREATMENT REGIMENS USING PI3K INHIBITORS
#6696-substituted estradiol derivatives for use in remyelination of nerve axons
#670Trace elements
#671ESTROGEN RECEPTOR MODULATORS FOR REDUCING BODY WEIGHT
#672Compositions and methods for protecting the kidney from ischemia reperfusion injury
#673Oromucosal Liquid Estradiol Compositions
#674Methods for inhibiting muscle atrophy
#675Methods of diagnosing and treating neonatal reversion to fetal consciousness
#676Oral transmucosal drug delivery system
#677PROGESTERONE CONTAINING ORAL DOSAGE FORMS AND KITS
#678Natural combination hormone replacement formulations and therapies
#679FULVESTRANT COMPOSITIONS
#680COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS
#681Encapsulated cells for hormone replacement therapy
#682NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#683ESTRADIOL CONTAINING TRANSDERMAL DRUG DELIVERY SYSTEMS AND COMPOSITIONS
#684Composition for Increasing Libido
#685Combination Therapy for the Treatment of Cancer
#686Reversely thermo-reversible hydrogel compositions
#687Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
#688Encapsulated cells for hormone replacement therapy
#689OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES
#690COMPOSITIONS HAVING C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY
#691CLASSIFICATION SYSTEM, METHODS AND KIT FOR CLASSIFYING, PREDICTING AND TREATING BREAST CANCER
#692Estrogen receptor mutations and uses thereof
#693COMPOSITIONS AND METHODS FOR MODULATING HIV ACTIVATION
#694Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
#695Applicator and system for administering and dispensing flowable pharmaceutical preparations
#696Fulvestrant formulations
#697Transmucosal hormone delivery system
#698Transdermal contraceptive hormones delivery
#699Transdermal contraceptive hormones delivery
#700Transdermal contraceptive hormones delivery
#701Estrogenic components for use in the treatment of neurological disorders
#702Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6S)-tetrahydrofolate
#703STABILITY OF PROGESTOGEN FORMULATIONS
#704ESTRIOL THERAPY FOR MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES
#705Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
#706Secnidazole for use in the treatment of bacterial vaginosis
#707Fulvestrant formulations
#708Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
#709METHOD FOR THE SEPARATION OF FUNCTIONAL INGREDIENTS IN PLACENTA
#710Compositions and methods for transdermal delivery of hormones and other medicinal agents
#711Therapeutic benefit of suboptimally administered chemical compounds
#712Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
#713Zoo-Technical Drug Delivery Device
#714Transdermal cream
#715Transdermal estrogen device and delivery
#716Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
#717INHIBITORS OF CDK8/19 FOR USE IN TREATING ESTROGEN RECEPTOR POSITIVE BREAST CANCER
#718Pheromone compositions and their use to modify behavior in different vertebrate species
#719Intrauterine device and method for reducing the rate of diffusion of active ingredients in said device by adding inert particulates to a polymeric coating
#720SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION
#721NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#722Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
#723Treatment of prostate carcinoma
#724Method for the treatment or prevention of lower urinary tract symptoms
#725Natural combination hormone replacement formulations and therapies
#726Production Of Inorganic-Organic Composite Materials By Reactive Spray-Drying
#727Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib
#728Chemical induction of lactation in male non-human mammals
#729COMPOSITIONS AND METHODS FOR HAIR GROWTH
#730Method of treating cancer using selective estrogen receptor modulators
#731Hormone Normalization Therapy and Uses Therefor
#732TRANSDERMAL ESTROGEN DEVICE AND DELIVERY
#7336-Substituted Estradiol Derivatives for the Treatment of Alzheimer's Disease
#734Compositions and methods for treating mammary tumors
#735LOW-DOSE ESTRADIOL CREAM
#736TRANSDERMAL SYSTEMS HAVING CONTROL DELIVERY SYSTEM
#737INTEROMONE COMPOSITIONS AND THEIR USE TO MODIFY BEHAVIOR IN DIFFERENT VERTEBRATE SPECIES
#738DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGR-1R AND ANTI-ERBB3 ANTIBODIES
#739Fulvestrant formulations
#740NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#741NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#742METHOD FOR TREATING INFLAMMATORY CONDITIONS
#743DRUG-ELUTING MEDICAL DEVICES
#744PHARMACEUTICAL COMPOSITION
#745NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF
#746SYSTEM FOR USE BY COMPOUNDING PHARMACISTS TO PRODUCE HORMONE REPLACEMENT MEDICINE CUSTOMIZED FOR EACH CUSTOMER
#747DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#748Pregnancy hormone combination for treatment of autoimmune diseases
#749CLEANSING COMPOSITION FOR HORMONE DEPOSITION
#750Apparatus, Composition, and Related Methods for Transdermal Delivery of Active Ingredients
#751Vaginal inserted estradiol pharmaceutical compositions and methods
#752Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
#753Intravaginal ring drug delivery system
#754Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
#755Progesterone formulations
#756SUBSTITUTED ANDROST-4-ENE DIONES
#757VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#758Estrogenic components for use in the treatment of neurological disorders
#759Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
#760COMPLEXES OF FULVESTRANT AND ITS DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#761Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase I
#762Pharmaceutical Combination of Resveratrol and Progestin to Treat and/or Prevent Myoma and/or Endometriosis
#763Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
#764Dissolvable-chewable tablet
#765Method and Substance for Improving the Emotional Development of an Infant
#766Very low-dosed solid oral dosage forms for HRT
#767Spreading implement
#768Method for the production of emulsion-based microparticles
#769ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASES AND DISORDERS
#770Vaginal inserted estradiol pharmaceutical compositions and methods
#771Pharmaceutical soft gelatin capsule dosage form with modified guar gum
#772Estrogen antagonists as treatments for sclerosing disorders
#773Kit-in-parts for cleaning and treating ears of companion animals
#774Natural combination hormone replacement formulations and therapies
#775COMPOSITIONS FOR AEROSOLIZATION OF HIGHLY CONDUCTIVE SOLUTIONS
#776Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis
#777Hormone Containing Emulsion Comprising Krill Phospholipids
#778Hormone containing emulsion
#779ANXIOLYTIC MARCGRAVIACEAE COMPOSITIONS CONTAINING BETULINIC ACID, BETULINIC ACID DERIVATIVES, AND METHODS
#780Methods and compositions for enhancing visual function
#781ESTROGEN RECEPTOR MODULATORS FOR REDUCING BODY WEIGHT
#782Combination of a RTK inhibitor with an anti-estrogen and use thereof for the treatment of cancer
#783Oromucosal liquid estradiol compositions
#784Natural combination hormone replacement formulations and therapies
#785Natural combination hormone replacement formulations and therapies
#786Natural combination hormone replacement formulations and therapies
#787Natural combination hormone replacement formulations and therapies
#788ESTRADIOL FORMULATIONS AND THERAPIES
#789Articles and methods of treating vascular conditions
#790Methods for inhibiting the development of Huntington's disease
#791Transdermal hormone replacement therapies
#792Adhesive patch assembly with overlay liner and system and method for making same
#793Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#794Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
#795Method for treatment of mesothelioma
#796Device for transdermal administration of drugs including acrylic polymers
#797AGENTS AND DEVICES FOR USE IN PREVENTION OF RESTENOSIS
#798Methods of treating heavy menstrual bleeding
#799TRANSDERMAL DRUG DELIVERY SYSTEM WITH OVERLAY
#800Transmucosal hormone delivery system
#801Pharmaceutical soft gelatin capsule dosage form with modified guar gum
#802PHARMACEUTICAL SOFT GELATIN CAPSULE DOSAGE FORM
#803Onapristone polymorphic forms and methods of use
#804CONTRACEPTIVE METHOD
#805COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS
#806Methods for lowering blood glucose
#807Soluble estradiol capsule for vaginal insertion
#808Transdermal estrogen device and delivery
#809Use of estetrol as emergency contraceptive
#810Combination therapy for skin disorders
#811Estrus synchronization preparations and effective CIDR-less protocols
#812Cyclodextrin nanotechnology for ophthalmic drug delivery
#813Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
#814HORMONE DELIVERY SYSTEM AND METHOD
#815Compositions and methods for transdermal delivery of hormones and other medicinal agents
#816COMPOSITIONS AND METHODS FOR TREATING CANCER
#817Oral transmucosal drug delivery system
#818Encapsulated cells for hormone replacement therapy
#819Intrauterine delivery system for contraception
#820Pregnancy hormone combination for treatment of autoimmune diseases
#821Process for the production of estetrol intermediates
#822Natural combination hormone replacement formulations and therapies
#823Natural combination hormone replacement formulations and therapies
#824Natural combination hormone replacement formulations and therapies
#825Natural combination hormone replacement formulations and therapies
#826Natural combination hormone replacement formulations and therapies
#827Natural combination hormone replacement formulations and therapies
#828Pharmaceutical composition
#829Compositions and methods for localized drug delivery through mammary papillae
#830Natural combination hormone replacement formulations and therapies
#831USE OF ANDROGEN FOR DISEASE TREATMENT
#832Methods and Compositions for the Treatment of Estrogen-Dependent Hyperproliferative Uterine Disorders
#833Combination therapies comprising anti-ERBB3 agents
#834Transdermal hormone delivery system: compositions and methods
#835DRUG DELIVERY SYSTEM
#836COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
#837Method for the treatment of multiple sclerosis
#838Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
#839Fulvestrant nanosphere/microsphere and preparative method and use thereof
#840TRANSDERMAL HORMONE COMPOSITION AND COMBINED STATIC-CYCLIC DELIVERY
#841Therapeutic compositions and methods
#842Myelin regeneration with androgens
#843Pharmaceutical composition and method for treating hypogonadism
#844METHOD FOR TREATING OR PREVENTING ANEMIA USING TESTIS EXTRACT AS ACTIVE INGREDIENT
#845COMBINATION BREAST CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS
#846Method for the treatment or prevention of lower urinary tract symptoms
#847FRANKINCENSE CHEWING GUM
#848Natural combination hormone replacement formulations and therapies
#849Methods and compositions for cancer prevention and treatment
#850TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS
#851Transdermal delivery system
#852Pharmaceutical composition and method for treating hypogonadism
#853MICROSPHERE DRUG CARRIER, PREPARATION METHOD, COMPOSITION AND USE THEREOF
#854Estriol therapy for multiple sclerosis and other autoimmune diseases
#855Fulvestrant compositions and methods of use
#856Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same
#857Barrel-shaped vaginal ring
#858Fulvestrant formulations
#859Formulation For Hormonotherapy
#860Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
#861Treatment of prostate carcinoma
#862Breast cancer therapeutics
#863ESTRIOL THERAPY FOR AUTOIMMUNE AND NEURODEGENERATIVE DISEASE AND DISORDERS
#864Novel IDO Inhibitors and Methods of Use Thereof
#865Pharmaceutical composition containing a tetrahydrofolic acid
#866Benzopyran compounds, compositions and uses thereof
#8675α-androstane (alkyl)-3β, 5, 6β-triol injection and preparation method therefor
#868USE OF AN ESTROGEN DERIVATIVE FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT AND/OR PREVENTION OF PSYCHIATRIC DISEASES AND FOR THE TREATMENT AND PREVENTION OF SAID DISEASES
#869Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
#870Hormonal composition and its use
#871Method of treating diabetes-related impaired wound healing
#872Transdermal estrogen device and delivery
#873Substituted triazolopyridines
#874COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS
#875Cyclodextrin nanotechnology for ophthalmic drug delivery
#876LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT
#877Natural combination hormone replacement formulations and therapies
#878Stable topical composition and a process for producing a stable topical composition
#879TRIAZOLOPYRIDINE DERIVATIVES
#880Neuroprotection and myelin repair using nestorone®
#881Drug delivery system
#882Ship inhibitors and uses thereof
#883Organic compounds
#884INDIBULIN THERAPY
#885Drug delivery system
#886Pheromone compositions and their use to modify behavior in different vertebrate species
#887COMPOSITION CONTAINING PLACENTA EXTRACTS
#888Pheromone compositions and their use to modify behavior in different vertebrate species
#889ANXIOYTIC MARCGRAVIACEAE COMPOSITIONS CONTAINING BETULINIC ACID, BETULINIC ACID DERIVATIVES, AND METHODS
#890Composition for enhancing transdermal absorption of a drug and patch preparation
#891Seizure and Migraine Treatments using Denosumab
#892Nestorone®/estradiol transdermal gel
#893C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
#894Progesterone containing oral dosage forms and kits
#895PHARMACEUTICAL COMPOSITION INCLUDING A TESTIS EXTRACT AS AN ACTIVE INGREDIENT FOR TREATING AND PREVENTING ANEMIA
#896Formulation
#897Estriol Therapy for Autoimmune and Neurodegenerative Diseases and Disorders
#898Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
#899Methods of treating hot flashes with formulations for transdermal or transmucosal application
#900Combination therapy for skin disorders